John Petersen
Cardiovascular Disease · Seattle, WANPI 1306926225
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Kiniksa Pharmaceuticals, Ltd. at 46.2% of the total. Reporting peaked in 2022 at $2,706 and has fallen 92.0% since, to $216 in 2024.
Across 23 payments — averaging $252.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kiniksa Pharmaceuticals, Ltd.$3K
- Cardiovascular Systems Inc.$2K
- Inari Medical, Inc.$360
- Corindus Inc.$243
- Teleflex LLC$139
- Boston Scientific$126
- plus $196 from 5 others
Across 90 payments — averaging $3363.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$115K
- Cardiovascular Systems Inc.$87K
- CSL Behring$55K
- Abbott$46K
What the payments were for
- Consulting fees$2,68046%
- Speaking & faculty fees$1,62028%
- Food & beverage$1,50126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | 1 | $2,680 |
| Cardiovascular Systems Inc. | 9 | $2,056 |
| Inari Medical, Inc. | 3 | $360 |
| Corindus Inc. | 1 | $243 |
| Teleflex LLC | 1 | $139 |
| Boston Scientific | 2 | $126 |
| Edwards Lifesciences | 1 | $63 |
| Abbott | 2 | $52 |
| Novartis | 1 | $39 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| Sanofi | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARCALYST$2,680
- Diamondback Coronary$1,743
- FLOWTRIEVER CATHETER, S$345
- CT THROMBECTOMY SYSTEM KIT$345
- CorPath GRX$243
- MANTA$139
- Coronary Orbital Atherectomy System$101
- SYNERGY$100
How this compares
$5,801 in reported general payments places this provider in the 85th percentile of 370 cardiovascular disease providers in Washington.
Other cardiovascular disease in Seattle
- Mariko HarperSeattle$246K
- Gary OppenheimSeattle$153K
- Kelley BranchSeattle$103K
- Erik WissnerSeattle$67K
- Younghoon KwonSeattle$66K
- Aron BenderSeattle$60K
- Vidhushei YogeswaranSeattle$55K
- Santanu BiswasSeattle$30K
- Bhanu GuptaSeattle$27K
- Michael LongoSeattle$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.